{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:20:35Z","timestamp":1789626035916,"version":"build-2803163510"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health, United States","award":["T32AG00026624"],"award-info":[{"award-number":["T32AG00026624"]}]},{"name":"National Institutes of Health, United States","award":["R01AG070193"],"award-info":[{"award-number":["R01AG070193"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG077556"],"award-info":[{"award-number":["R21AG077556"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARFD-21-850893"],"award-info":[{"award-number":["AARFD-21-850893"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synapse function is critical for cognition, and synapse loss is highly correlated with cognitive decline in Alzheimer\u2019s disease and related dementias. Tau oligomers, which accumulate in the brain in Alzheimer\u2019s disease, can acutely inhibit synaptic plasticity and cause synapse loss. Coordinated presynaptic and postsynaptic function is essential for effective synaptic transmission, and both compartments can be dysregulated by pathogenic tau. However, the series of pathophysiological events triggered by tau oligomers to cause the dysfunction and deterioration of presynaptic terminals and postsynaptic sites remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a proximity labeling tool to map the postsynaptic proteome by fusing PSD-95 with APEX2 (APEX2-PSD-95) which was expressed in human induced pluripotent stem cell (iPSC)-derived neurons. We used APEX2-PSD-95 to map the dynamic changes in the postsynaptic proteome with precise temporal resolution after an acute exposure of human iPSC-derived neurons to recombinant tau oligomers for 30\u00a0min. Leveraging immunocytochemistry, electrophysiology and electron microscopy, we further delineated the impact of the acute tau oligomer exposure on presynaptic and postsynaptic compartments over time for up to 14 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The brief exposure of human iPSC-derived neurons to tau oligomers caused a progressive deterioration of synapses, marked by both presynaptic and postsynaptic dysregulation. Postsynaptic proteome mapping revealed an immediate tau oligomer-triggered downregulation of the postsynaptic actin motor proteins Myosin-Va and Myosin IIb, which coincided with impaired AMPA receptor (AMPAR) trafficking during synaptic plasticity. This was followed 24\u00a0h later by the upregulation of disease-related proteins, including GSK3\u03b2, at postsynaptic sites. The loss of PSD-95-labeled postsynaptic sites at 7 days after tau oligomer exposure preceded the loss of Synapsin-labeled presynaptic terminals at 14 days. The postsynaptic sites that remained exhibited a long-term downregulation of postsynaptic AMPAR levels and sustained synaptic plasticity impairment. Moreover, the remaining presynaptic terminals contained less clusters of vesicles at the presynaptic active zone which was associated with reduced vesicle release probability at synapses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings reveal the series of events underlying tau oligomer-induced bipartite synapse deterioration. The progressive decline of synapses involves the emergence of two synapse fates. One synapse fate involves the persistent weakening of both presynaptic and postsynaptic function, and the other results in synaptic loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-026-00928-2","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:55:05Z","timestamp":1769108105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss"],"prefix":"10.1186","volume":"21","author":[{"given":"Kristeen A.","family":"Pareja-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina D.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Kauwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani Y.","family":"Ngwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doyle","family":"Lokitiyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaryan","family":"Vira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat","family":"Malak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuankai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara E.","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"5","key":"928_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol. 1990;27(5):457\u201364.","journal-title":"Ann Neurol"},{"issue":"4","key":"928_CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380.","journal-title":"Ann Neurol"},{"issue":"9","key":"928_CR3","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41380-024-02501-z","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer\u2019s disease. Mol Psychiatry. 2024;29(9):2799\u2013809.","journal-title":"Mol Psychiatry"},{"key":"928_CR4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","volume":"51","author":"TE Tracy","year":"2018","unstructured":"Tracy TE, Gan L. Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease. Curr Opin Neurobiol. 2018;51:134\u20138.","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"928_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener. 2021;10(1):45.","journal-title":"Transl Neurodegener"},{"key":"928_CR6","doi-asserted-by":"crossref","unstructured":"Rawat P, et al. Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. 2022;23(21).","DOI":"10.3390\/ijms232112841"},{"issue":"1","key":"928_CR7","doi-asserted-by":"crossref","first-page":"101442","DOI":"10.1016\/j.jbc.2021.101442","volume":"298","author":"DM Acosta","year":"2022","unstructured":"Acosta DM, et al. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation. J Biol Chem. 2022;298(1):101442.","journal-title":"J Biol Chem"},{"issue":"21","key":"928_CR8","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/acschemneuro.3c00578","volume":"14","author":"SJA Shah","year":"2023","unstructured":"Shah SJA, et al. Identification of aggregation mechanism of acetylated PHF6* and PHF6 tau peptides based on molecular dynamics simulations and Markov state modeling. ACS Chem Neurosci. 2023;14(21):3959\u201371.","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"928_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.07.029","volume":"223","author":"AB Rocher","year":"2010","unstructured":"Rocher AB, et al. Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs. Exp Neurol. 2010;223(2):385\u201393.","journal-title":"Exp Neurol"},{"issue":"5733","key":"928_CR10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science. 2005;309(5733):476\u201381.","journal-title":"Science"},{"issue":"3","key":"928_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2005.11.009","volume":"54","author":"S Maeda","year":"2006","unstructured":"Maeda S, et al. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer\u2019s disease. Neurosci Res. 2006;54(3):197\u2013201.","journal-title":"Neurosci Res"},{"issue":"5","key":"928_CR12","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, et al. Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. Faseb J. 2012;26(5):1946\u201359.","journal-title":"Faseb J"},{"key":"928_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener. 2011;6:39.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"928_CR14","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2353\/ajpath.2006.050840","volume":"168","author":"TL Spires","year":"2006","unstructured":"Spires TL, et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol. 2006;168(5):1598\u2013607.","journal-title":"Am J Pathol"},{"issue":"14","key":"928_CR15","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","volume":"27","author":"Z Berger","year":"2007","unstructured":"Berger Z, et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci. 2007;27(14):3650\u201362.","journal-title":"J Neurosci"},{"issue":"4","key":"928_CR16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"HC Tai","year":"2012","unstructured":"Tai HC, et al. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181(4):1426\u201335.","journal-title":"Am J Pathol"},{"issue":"6","key":"928_CR17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1750-3639.2012.00598.x","volume":"22","author":"KM Henkins","year":"2012","unstructured":"Henkins KM, et al. Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer\u2019s cortical synapses. Brain Pathol. 2012;22(6):826\u201333.","journal-title":"Brain Pathol"},{"issue":"11","key":"928_CR18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei RN, et al. Tau Oligomer-Containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol. 2023;80(11):1209\u201321.","journal-title":"JAMA Neurol"},{"issue":"14","key":"928_CR19","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","volume":"111","author":"M Colom-Cadena","year":"2023","unstructured":"Colom-Cadena M, et al. Synaptic oligomeric tau in Alzheimer\u2019s disease - A potential culprit in the spread of tau pathology through the brain. Neuron. 2023;111(14):2170\u201383. .e6.","journal-title":"Neuron"},{"issue":"4","key":"928_CR20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3233\/JAD-200716","volume":"78","author":"A Singh","year":"2020","unstructured":"Singh A, et al. Functional integrity of synapses in the central nervous system of cognitively intact individuals with high Alzheimer\u2019s disease neuropathology is associated with absence of synaptic tau oligomers. J Alzheimers Dis. 2020;78(4):1661\u201378.","journal-title":"J Alzheimers Dis"},{"key":"928_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fneur.2013.00093","volume":"4","author":"JE Gerson","year":"2013","unstructured":"Gerson JE, Kayed R. Formation and propagation of tau oligomeric seeds. Front Neurol. 2013;4:93.","journal-title":"Front Neurol"},{"issue":"9","key":"928_CR22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA, et al. Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci. 2020;77(9):1721\u201344.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"928_CR23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/acn3.382","volume":"4","author":"U Sengupta","year":"2017","unstructured":"Sengupta U, et al. Tau oligomers in cerebrospinal fluid in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2017;4(4):226\u201335.","journal-title":"Ann Clin Transl Neurol"},{"key":"928_CR24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous Tau. Sci Rep. 2012;2:700.","journal-title":"Sci Rep"},{"key":"928_CR25","doi-asserted-by":"crossref","first-page":"579434","DOI":"10.3389\/fneur.2020.579434","volume":"11","author":"L Jiang","year":"2020","unstructured":"Jiang L, et al. Tau oligomers and fibrils exhibit differential patterns of seeding and association with RNA binding proteins. Front Neurol. 2020;11:579434.","journal-title":"Front Neurol"},{"issue":"5","key":"928_CR26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41419-020-2503-3","volume":"11","author":"N Puangmalai","year":"2020","unstructured":"Puangmalai N, et al. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer\u2019s disease, progressive supranuclear palsy and dementia with lewy bodies. Cell Death Dis. 2020;11(5):314.","journal-title":"Cell Death Dis"},{"issue":"42","key":"928_CR27","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic M, et al. Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells. J Neurosci. 2015;35(42):14234\u201350.","journal-title":"J Neurosci"},{"issue":"2","key":"928_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuron.2016.12.015","volume":"93","author":"RA Nicoll","year":"2017","unstructured":"Nicoll RA. A brief history of Long-Term potentiation. Neuron. 2017;93(2):281\u201390.","journal-title":"Neuron"},{"key":"928_CR29","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","volume":"6","author":"M F\u00e1","year":"2016","unstructured":"F\u00e1 M, et al. Extracellular tau oligomers produce an immediate impairment of LTP and memory. Sci Rep. 2016;6:19393.","journal-title":"Sci Rep"},{"key":"928_CR30","doi-asserted-by":"crossref","unstructured":"Puzzo D, et al. LTP and memory impairment caused by extracellular A\u03b2 and tau oligomers is APP-dependent. Elife. 2017;6.","DOI":"10.7554\/eLife.26991"},{"issue":"1","key":"928_CR31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-019-0326-4","volume":"14","author":"E Acquarone","year":"2019","unstructured":"Acquarone E, et al. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade. Mol Neurodegener. 2019;14(1):26.","journal-title":"Mol Neurodegener"},{"key":"928_CR32","doi-asserted-by":"crossref","unstructured":"Hill E, et al. Introduction of tau oligomers into cortical neurons alters action potential dynamics and disrupts synaptic transmission and plasticity. eNeuro. 2019;6(5).","DOI":"10.1523\/ENEURO.0166-19.2019"},{"issue":"1","key":"928_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-025-01930-3","volume":"13","author":"C Balducci","year":"2025","unstructured":"Balducci C, et al. Tau oligomers impair memory and synaptic plasticity through the cellular prion protein. Acta Neuropathol Commun. 2025;13(1):17.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"928_CR34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13041-025-01208-8","volume":"18","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. Divergent disruptive effects of soluble Recombinant tau assemblies on synaptic plasticity in vivo. Mol Brain. 2025;18(1):36.","journal-title":"Mol Brain"},{"key":"928_CR35","first-page":"464","volume":"9","author":"MJ Guerrero-Mu\u00f1oz","year":"2015","unstructured":"Guerrero-Mu\u00f1oz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: the toxic player at synapses in Alzheimer\u2019s disease. Front Cell Neurosci. 2015;9:464.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"928_CR36","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jalz.2017.04.002","volume":"13","author":"S Kaniyappan","year":"2017","unstructured":"Kaniyappan S, et al. Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability. Alzheimers Dement. 2017;13(11):1270\u201391.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"928_CR37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/j.1460-9568.2006.05032.x","volume":"24","author":"Y Kamikubo","year":"2006","unstructured":"Kamikubo Y, et al. Long-lasting synaptic loss after repeated induction of LTD: independence to the means of LTD induction. Eur J Neurosci. 2006;24(6):1606\u201316.","journal-title":"Eur J Neurosci"},{"issue":"1633","key":"928_CR38","doi-asserted-by":"crossref","first-page":"20130138","DOI":"10.1098\/rstb.2013.0138","volume":"369","author":"M Sheng","year":"2014","unstructured":"Sheng M, Ert\u00fcrk A. Long-term depression: a cell biological view. Philos Trans R Soc Lond B Biol Sci. 2014;369(1633):20130138.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"928_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1073858418769644","volume":"25","author":"IS Stein","year":"2019","unstructured":"Stein IS, Zito K. Dendritic spine elimination: molecular mechanisms and implications. Neuroscientist. 2019;25(1):27\u201347.","journal-title":"Neuroscientist"},{"issue":"5","key":"928_CR40","doi-asserted-by":"crossref","first-page":"fcae333","DOI":"10.1093\/braincomms\/fcae333","volume":"6","author":"NW Hu","year":"2024","unstructured":"Hu NW, et al. Patient-derived tau and amyloid-\u03b2 facilitate long-term depression in vivo: role of tumour necrosis factor-\u03b1 and the integrated stress response. Brain Commun. 2024;6(5):fcae333.","journal-title":"Brain Commun"},{"key":"928_CR41","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fnins.2018.00963","volume":"12","author":"M Marttinen","year":"2018","unstructured":"Marttinen M, et al. Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer\u2019s disease. Front Neurosci. 2018;12:963.","journal-title":"Front Neurosci"},{"issue":"4","key":"928_CR42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.stemcr.2017.08.019","volume":"9","author":"C Wang","year":"2017","unstructured":"Wang C, et al. Scalable production of iPSC-Derived human neurons to identify Tau-Lowering compounds by High-Content screening. Stem Cell Rep. 2017;9(4):1221\u201333.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"928_CR43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1017\/S1551929513000485","volume":"21","author":"L Cohen-Gould","year":"2013","unstructured":"Cohen-Gould L. Handling cell culture monolayers for transmission electron microscopy. Microscopy Today. 2013;21(3):36\u20139.","journal-title":"Microscopy Today"},{"issue":"1","key":"928_CR44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nmeth.3179","volume":"12","author":"SS Lam","year":"2015","unstructured":"Lam SS, et al. Directed evolution of APEX2 for electron microscopy and proximity labeling. Nat Methods. 2015;12(1):51\u20134.","journal-title":"Nat Methods"},{"issue":"2","key":"928_CR45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuron.2007.11.027","volume":"57","author":"W Xu","year":"2008","unstructured":"Xu W, et al. Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD. Neuron. 2008;57(2):248\u201362.","journal-title":"Neuron"},{"issue":"6","key":"928_CR46","doi-asserted-by":"crossref","first-page":"pO111016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet LC, et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteom. 2012;11(6):pO111016717.","journal-title":"Mol Cell Proteom"},{"issue":"12","key":"928_CR47","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1074\/mcp.RA117.000314","volume":"16","author":"R Bruderer","year":"2017","unstructured":"Bruderer R, et al. Optimization of experimental parameters in Data-Independent mass spectrometry significantly increases depth and reproducibility of results. Mol Cell Proteom. 2017;16(12):2296\u2013309.","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"928_CR48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","volume":"8","author":"BC Collins","year":"2017","unstructured":"Collins BC, et al. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nat Commun. 2017;8(1):291.","journal-title":"Nat Commun"},{"issue":"1","key":"928_CR49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acs.jproteome.7b00170","volume":"17","author":"T Burger","year":"2018","unstructured":"Burger T. Gentle introduction to the statistical foundations of false discovery rate in quantitative proteomics. J Proteome Res. 2018;17(1):12\u201322.","journal-title":"J Proteome Res"},{"issue":"2","key":"928_CR50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuron.2019.05.002","volume":"103","author":"F Koopmans","year":"2019","unstructured":"Koopmans F, et al. SynGO: an Evidence-Based, Expert-Curated knowledge base for the synapse. Neuron. 2019;103(2):217\u2013e2344.","journal-title":"Neuron"},{"issue":"3","key":"928_CR51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"43","key":"928_CR52","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"928_CR53","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"928_CR54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, et al. ClueGO: a cytoscape plug-in to Decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091\u20133.","journal-title":"Bioinformatics"},{"key":"928_CR55","doi-asserted-by":"crossref","unstructured":"Kauwe G, et al. KIBRA repairs synaptic plasticity and promotes resilience to tauopathy-related memory loss. J Clin Invest. 2024;134(3).","DOI":"10.1172\/JCI169064"},{"key":"928_CR56","doi-asserted-by":"crossref","unstructured":"Kauwe G, et al. Pathogenic tau inhibits synaptic plasticity by blocking eIF4B-mediated local protein synthesis. bioRxiv, 2025: p. 2025.09.11.675671.","DOI":"10.1101\/2025.09.11.675671"},{"issue":"5","key":"928_CR57","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2016.07.041","volume":"166","author":"KH Loh","year":"2016","unstructured":"Loh KH, et al. Proteomic analysis of unbounded cellular compartments: synaptic clefts. Cell. 2016;166(5):1295\u2013e130721.","journal-title":"Cell"},{"issue":"4","key":"928_CR58","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy TE, et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. 2022;185(4):712\u2013e72814.","journal-title":"Cell"},{"key":"928_CR59","doi-asserted-by":"crossref","unstructured":"Liao S, et al. Identification of the B7-H3 interaction partners using a proximity labeling strategy. Int J Mol Sci. 2025;26(4).","DOI":"10.3390\/ijms26041731"},{"issue":"1","key":"928_CR60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13024-023-00673-w","volume":"18","author":"S Hasan","year":"2023","unstructured":"Hasan S, et al. Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons. Mol Neurodegener. 2023;18(1):87.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"928_CR61","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2013.04.017","volume":"78","author":"GG Gross","year":"2013","unstructured":"Gross GG, et al. Recombinant probes for visualizing endogenous synaptic proteins in living neurons. Neuron. 2013;78(6):971\u201385.","journal-title":"Neuron"},{"issue":"1","key":"928_CR62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nn.2719","volume":"14","author":"A Bay\u00e9s","year":"2011","unstructured":"Bay\u00e9s A, et al. Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci. 2011;14(1):19\u201321.","journal-title":"Nat Neurosci"},{"issue":"4","key":"928_CR63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nn2063","volume":"11","author":"SS Correia","year":"2008","unstructured":"Correia SS, et al. Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. Nat Neurosci. 2008;11(4):457\u201366.","journal-title":"Nat Neurosci"},{"issue":"8","key":"928_CR64","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s12264-023-01174-y","volume":"40","author":"R Gong","year":"2024","unstructured":"Gong R, et al. Myosin Va-dependent transport of NMDA receptors in hippocampal neurons. Neurosci Bull. 2024;40(8):1053\u201375.","journal-title":"Neurosci Bull"},{"issue":"4","key":"928_CR65","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1523\/JNEUROSCI.3294-10.2011","volume":"31","author":"MD Rubio","year":"2011","unstructured":"Rubio MD, et al. Regulation of synapse structure and function by distinct myosin II motors. J Neurosci. 2011;31(4):1448\u201360.","journal-title":"J Neurosci"},{"issue":"4","key":"928_CR66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2010.07.016","volume":"67","author":"CS Rex","year":"2010","unstructured":"Rex CS, et al. Myosin IIb regulates actin dynamics during synaptic plasticity and memory formation. Neuron. 2010;67(4):603\u201317.","journal-title":"Neuron"},{"issue":"1","key":"928_CR67","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","volume":"14","author":"M Askenazi","year":"2023","unstructured":"Askenazi M, et al. Compilation of reported protein changes in the brain in Alzheimer\u2019s disease. Nat Commun. 2023;14(1):4466.","journal-title":"Nat Commun"},{"issue":"2","key":"928_CR68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25(2):213\u201325.","journal-title":"Nat Neurosci"},{"key":"928_CR69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s42003-018-0254-9","volume":"2","author":"J Xu","year":"2019","unstructured":"Xu J, et al. Regional protein expression in human Alzheimer\u2019s brain correlates with disease severity. Commun Biol. 2019;2:43.","journal-title":"Commun Biol"},{"issue":"1","key":"928_CR70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, et al. A Multi-network approach identifies Protein-Specific Co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 2017;4(1):60\u2013e724.","journal-title":"Cell Syst"},{"issue":"1","key":"928_CR71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","volume":"13","author":"ECB Johnson","year":"2018","unstructured":"Johnson ECB, et al. Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener. 2018;13(1):52.","journal-title":"Mol Neurodegener"},{"issue":"3\u20134","key":"928_CR72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/prca.201100068","volume":"6","author":"LE Donovan","year":"2012","unstructured":"Donovan LE, et al. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer\u2019s disease. Proteom Clin Appl. 2012;6(3\u20134):201\u201311.","journal-title":"Proteom Clin Appl"},{"issue":"5","key":"928_CR73","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769\u201380.","journal-title":"Nat Med"},{"issue":"6","key":"928_CR74","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41593-020-0635-5","volume":"23","author":"AP Wingo","year":"2020","unstructured":"Wingo AP, et al. Shared proteomic effects of cerebral atherosclerosis and Alzheimer\u2019s disease on the human brain. Nat Neurosci. 2020;23(6):696\u2013700.","journal-title":"Nat Neurosci"},{"issue":"7","key":"928_CR75","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1074\/mcp.M115.056580","volume":"15","author":"RA Sweet","year":"2016","unstructured":"Sweet RA, et al. Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease. Mol Cell Proteom. 2016;15(7):2252\u201362.","journal-title":"Mol Cell Proteom"},{"key":"928_CR76","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1038\/srep11138","volume":"5","author":"J Ho Kim","year":"2015","unstructured":"Ho Kim J, et al. Proteome-wide characterization of signalling interactions in the hippocampal CA4\/DG subfield of patients with Alzheimer\u2019s disease. Sci Rep. 2015;5:11138.","journal-title":"Sci Rep"},{"issue":"1","key":"928_CR77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-018-0524-2","volume":"6","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, et al. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6(1):19.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"928_CR78","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143\u201353.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"928_CR79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mam.2008.08.009","volume":"30","author":"CC Franklin","year":"2009","unstructured":"Franklin CC, et al. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med. 2009;30(1\u20132):86\u201398.","journal-title":"Mol Aspects Med"},{"issue":"24","key":"928_CR80","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1074\/jbc.M414635200","volume":"280","author":"AY Shih","year":"2005","unstructured":"Shih AY, et al. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem. 2005;280(24):22925\u201336.","journal-title":"J Biol Chem"},{"key":"928_CR81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"52","key":"928_CR82","doi-asserted-by":"crossref","first-page":"41340","DOI":"10.1074\/jbc.M006219200","volume":"275","author":"K Spittaels","year":"2000","unstructured":"Spittaels K, et al. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau Transgenic mice. J Biol Chem. 2000;275(52):41340\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"928_CR83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","volume":"147","author":"DP Hanger","year":"1992","unstructured":"Hanger DP, et al. Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett. 1992;147(1):58\u201362.","journal-title":"Neurosci Lett"},{"issue":"5","key":"928_CR84","doi-asserted-by":"crossref","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D. Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res. 2020;1867(5):118664.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"928_CR85","doi-asserted-by":"crossref","first-page":"p4209475","DOI":"10.1155\/2019\/4209475","volume":"2019","author":"T Jaworski","year":"2019","unstructured":"Jaworski T, Banach-Kasper E, Gralec K. GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration. Neural Plast. 2019;2019:p4209475.","journal-title":"Neural Plast"},{"key":"928_CR86","doi-asserted-by":"crossref","unstructured":"Sayas CL, \u00c1vila J. GSK-3 and Tau: a key duet in Alzheimer\u2019s disease. Cells. 2021;10(4).","DOI":"10.3390\/cells10040721"},{"issue":"1","key":"928_CR87","first-page":"S428","volume":"153","author":"S Peineau","year":"2008","unstructured":"Peineau S, et al. The role of GSK-3 in synaptic plasticity. Br J Pharmacol. 2008;153(1):S428\u201337.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"928_CR88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1460-9568.2006.05245.x","volume":"25","author":"C Hooper","year":"2007","unstructured":"Hooper C, et al. Glycogen synthase kinase-3 Inhibition is integral to long-term potentiation. Eur J Neurosci. 2007;25(1):81\u20136.","journal-title":"Eur J Neurosci"},{"issue":"45","key":"928_CR89","doi-asserted-by":"crossref","first-page":"12211","DOI":"10.1523\/JNEUROSCI.3321-07.2007","volume":"27","author":"LQ Zhu","year":"2007","unstructured":"Zhu LQ, et al. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J Neurosci. 2007;27(45):12211\u201320.","journal-title":"J Neurosci"},{"issue":"5","key":"928_CR90","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","volume":"53","author":"S Peineau","year":"2007","unstructured":"Peineau S, et al. LTP inhibits LTD in the hippocampus via regulation of GSK3\u03b2eta. Neuron. 2007;53(5):703\u201317.","journal-title":"Neuron"},{"key":"928_CR91","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/ncomms3759","volume":"4","author":"S Matsuda","year":"2013","unstructured":"Matsuda S, et al. Stargazin regulates AMPA receptor trafficking through adaptor protein complexes during long-term depression. Nat Commun. 2013;4:2759.","journal-title":"Nat Commun"},{"issue":"1","key":"928_CR92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuron.2011.09.034","volume":"73","author":"T Unoki","year":"2012","unstructured":"Unoki T, et al. NMDA receptor-mediated PIP5K activation to produce PI(4,5)P\u2082 is essential for AMPA receptor endocytosis during LTD. Neuron. 2012;73(1):135\u201348.","journal-title":"Neuron"},{"issue":"5","key":"928_CR93","first-page":"302","volume":"35","author":"ERS Kunji","year":"2020","unstructured":"Kunji ERS, et al. The SLC25 carrier family: important transport proteins in mitochondrial physiology and pathology. Physiol (Bethesda). 2020;35(5):302\u201327.","journal-title":"Physiol (Bethesda)"},{"issue":"3","key":"928_CR94","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/clinem\/dgab790","volume":"107","author":"P Jungtrakoon Thamtarana","year":"2022","unstructured":"Jungtrakoon Thamtarana P, et al. Gain of function of malate dehydrogenase 2 and Familial hyperglycemia. J Clin Endocrinol Metab. 2022;107(3):668\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"928_CR95","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.molcel.2022.02.028","volume":"82","author":"A De Jesus","year":"2022","unstructured":"De Jesus A, et al. Hexokinase 1 cellular localization regulates the metabolic fate of glucose. Mol Cell. 2022;82(7):1261\u2013e12779.","journal-title":"Mol Cell"},{"issue":"s1","key":"928_CR96","doi-asserted-by":"crossref","first-page":"S453","DOI":"10.3233\/JAD-220514","volume":"94","author":"N Chhimpa","year":"2023","unstructured":"Chhimpa N, et al. The novel role of mitochondrial citrate synthase and citrate in the pathophysiology of Alzheimer\u2019s disease. J Alzheimers Dis. 2023;94(s1):S453\u201372.","journal-title":"J Alzheimers Dis"},{"key":"928_CR97","doi-asserted-by":"crossref","unstructured":"Han R, Liang J, Zhou B. Glucose metabolic dysfunction in neurodegenerative diseases-new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming. Int J Mol Sci. 2021;22(11).","DOI":"10.3390\/ijms22115887"},{"issue":"10","key":"928_CR98","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.cell.2024.03.015","volume":"187","author":"C Parra Bravo","year":"2024","unstructured":"Parra Bravo C, et al. Human iPSC 4R Tauopathy model uncovers modifiers of tau propagation. Cell. 2024;187(10):2446\u2013e246422.","journal-title":"Cell"},{"issue":"1","key":"928_CR99","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13024-024-00786-w","volume":"19","author":"AT Marvian","year":"2024","unstructured":"Marvian AT, et al. Distinct regulation of tau monomer and aggregate uptake and intracellular accumulation in human neurons. Mol Neurodegener. 2024;19(1):100.","journal-title":"Mol Neurodegener"},{"key":"928_CR100","doi-asserted-by":"crossref","unstructured":"Pardo E, et al. Mitochondrial NADK2-dependent NADPH controls tau oligomer uptake in human neurons. bioRxiv. 2024.","DOI":"10.1101\/2024.10.31.621392"},{"issue":"1","key":"928_CR101","doi-asserted-by":"crossref","first-page":"e12029","DOI":"10.1002\/trc2.12029","volume":"6","author":"J Caneus","year":"2020","unstructured":"Caneus J, et al. A human induced pluripotent stem cell-derived cortical neuron human-on-a chip system to study A\u03b2(42) and tau-induced pathophysiological effects on long-term potentiation. Alzheimers Dement (N Y). 2020;6(1):e12029.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"5","key":"928_CR102","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0197-4580(00)00157-3","volume":"21","author":"CL Weaver","year":"2000","unstructured":"Weaver CL, et al. Conformational change as one of the earliest alterations of tau in Alzheimer\u2019s disease. Neurobiol Aging. 2000;21(5):719\u201327.","journal-title":"Neurobiol Aging"},{"key":"928_CR103","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun. 2017;8:15295.","journal-title":"Nat Commun"},{"issue":"4","key":"928_CR104","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes J, et al. Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron. 2018;97(4):823\u2013e8358.","journal-title":"Neuron"},{"key":"928_CR105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ceb.2021.02.007","volume":"71","author":"S Reshetniak","year":"2021","unstructured":"Reshetniak S, Rizzoli SO. The vesicle cluster as a major organizer of synaptic composition in the short-term and long-term. Curr Opin Cell Biol. 2021;71:63\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"928_CR106","doi-asserted-by":"crossref","unstructured":"Hammer JA 3rd and, Sellers JR. Walking to work: roles for class V myosins as cargo transporters. Nat Rev Mol Cell Biol. 2011;13(1):13\u201326.","DOI":"10.1038\/nrm3248"},{"issue":"1","key":"928_CR107","doi-asserted-by":"crossref","first-page":"16238","DOI":"10.1038\/s41598-019-52543-5","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L tau to non-muscle myosins. Sci Rep. 2019;9(1):16238.","journal-title":"Sci Rep"},{"issue":"32","key":"928_CR108","doi-asserted-by":"crossref","first-page":"23645","DOI":"10.1074\/jbc.M703269200","volume":"282","author":"DP Hanger","year":"2007","unstructured":"Hanger DP, et al. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem. 2007;282(32):23645\u201354.","journal-title":"J Biol Chem"},{"issue":"6","key":"928_CR109","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/acschemneuro.9b00459","volume":"11","author":"GS Nuebling","year":"2020","unstructured":"Nuebling GS, et al. Binding of Metal-Ion-Induced tau oligomers to lipid surfaces is enhanced by GSK-3\u03b2-Mediated phosphorylation. ACS Chem Neurosci. 2020;11(6):880\u20137.","journal-title":"ACS Chem Neurosci"},{"key":"928_CR110","doi-asserted-by":"crossref","unstructured":"Marcatti M, et al. Inhibition of calcineurin with FK506 reduces tau levels and attenuates synaptic impairment driven by tau oligomers in the hippocampus of male mouse models. Int J Mol Sci. 2024;25(16).","DOI":"10.3390\/ijms25169092"},{"issue":"15","key":"928_CR111","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1093\/hmg\/ddab363","volume":"31","author":"F Du","year":"2022","unstructured":"Du F, et al. Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer\u2019s disease. Hum Mol Genet. 2022;31(15):2498\u2013507.","journal-title":"Hum Mol Genet"},{"key":"928_CR112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","volume":"9","author":"SS Shafiei","year":"2017","unstructured":"Shafiei SS, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL. Tau oligomers: Cytotoxicity, Propagation, and mitochondrial damage. Front Aging Neurosci. 2017;9:83.","journal-title":"Front Aging Neurosci"},{"key":"928_CR113","doi-asserted-by":"crossref","unstructured":"Spina E, et al. Mitochondrial alterations, oxidative stress, and therapeutic implications in Alzheimer\u2019s disease: a narrative review. Cells, 2025;14(3).","DOI":"10.3390\/cells14030229"},{"key":"928_CR114","doi-asserted-by":"crossref","first-page":"148545","DOI":"10.1016\/j.brainres.2023.148545","volume":"1819","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer\u2019s disease. Brain Res. 2023;1819:148545.","journal-title":"Brain Res"},{"issue":"3","key":"928_CR115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3233\/JAD-170168","volume":"58","author":"E Swanson","year":"2017","unstructured":"Swanson E, et al. Extracellular tau oligomers induce invasion of endogenous tau into the somatodendritic compartment and axonal transport dysfunction. J Alzheimers Dis. 2017;58(3):803\u201320.","journal-title":"J Alzheimers Dis"},{"key":"928_CR116","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-981-32-9358-8_23","volume":"1184","author":"S Dujardin","year":"2019","unstructured":"Dujardin S, Hyman BT. Tau Prion-Like propagation: state of the Art and current challenges. Adv Exp Med Biol. 2019;1184:305\u201325.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"928_CR117","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00401-018-1937-5","volume":"137","author":"L Jiang","year":"2019","unstructured":"Jiang L, et al. TIA1 regulates the generation and response to toxic tau oligomers. Acta Neuropathol. 2019;137(2):259\u201377.","journal-title":"Acta Neuropathol"},{"key":"928_CR118","doi-asserted-by":"crossref","first-page":"30498","DOI":"10.1038\/srep30498","volume":"6","author":"CA Brunello","year":"2016","unstructured":"Brunello CA, Yan X, Huttunen HJ. Internalized tau sensitizes cells to stress by promoting formation and stability of stress granules. Sci Rep. 2016;6:30498.","journal-title":"Sci Rep"},{"issue":"20","key":"928_CR119","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1016\/j.molcel.2021.07.038","volume":"81","author":"L Jiang","year":"2021","unstructured":"Jiang L, et al. Interaction of tau with HNRNPA2B1 and N(6)-methyladenosine RNA mediates the progression of Tauopathy. Mol Cell. 2021;81(20):4209\u2013e422712.","journal-title":"Mol Cell"},{"issue":"3","key":"928_CR120","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/alz.13535","volume":"20","author":"X Sun","year":"2024","unstructured":"Sun X, et al. Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers. Alzheimers Dement. 2024;20(3):1656\u201370.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"928_CR121","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3233\/JAD-221284","volume":"93","author":"MN Best","year":"2023","unstructured":"Best MN, et al. Extracellular tau oligomers damage the axon initial segment. J Alzheimer\u2019s Disease. 2023;93(4):1425\u201341.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"3","key":"928_CR122","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.24716","volume":"80","author":"S Takeda","year":"2016","unstructured":"Takeda S, et al. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer\u2019s disease mouse model and human patients. Ann Neurol. 2016;80(3):355\u201367.","journal-title":"Ann Neurol"},{"key":"928_CR123","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1038\/ncomms9490","volume":"6","author":"S Takeda","year":"2015","unstructured":"Takeda S, et al. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer\u2019s disease brain. Nat Commun. 2015;6:8490.","journal-title":"Nat Commun"},{"issue":"1","key":"928_CR124","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s42003-025-07499-w","volume":"8","author":"F Lo Cascio","year":"2025","unstructured":"Lo Cascio F, et al. Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities. Commun Biol. 2025;8(1):53.","journal-title":"Commun Biol"},{"issue":"47","key":"928_CR125","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","volume":"49","author":"CA Lasagna-Reeves","year":"2010","unstructured":"Lasagna-Reeves CA, et al. Preparation and characterization of neurotoxic tau oligomers. Biochemistry. 2010;49(47):10039\u201341.","journal-title":"Biochemistry"},{"issue":"17","key":"928_CR126","doi-asserted-by":"crossref","first-page":"168194","DOI":"10.1016\/j.jmb.2023.168194","volume":"435","author":"H Rasmussen","year":"2023","unstructured":"Rasmussen H, et al. Tau fibrillation induced by heparin or a lysophospholipid show different initial oligomer formation. J Mol Biol. 2023;435(17):168194.","journal-title":"J Mol Biol"},{"issue":"26","key":"928_CR127","doi-asserted-by":"crossref","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","volume":"286","author":"KR Patterson","year":"2011","unstructured":"Patterson KR, et al. Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease. J Biol Chem. 2011;286(26):23063\u201376.","journal-title":"J Biol Chem"},{"key":"928_CR128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.mcb.2017.06.005","volume":"141","author":"B Combs","year":"2017","unstructured":"Combs B, et al. Production of Recombinant tau oligomers in vitro. Methods Cell Biol. 2017;141:45\u201364.","journal-title":"Methods Cell Biol"},{"key":"928_CR129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-7816-8_7","volume":"1779","author":"EK Argyrousi","year":"2018","unstructured":"Argyrousi EK, et al. Preparation of tau oligomers after the protein extraction from bacteria and brain cortices. Methods Mol Biol. 2018;1779:85\u201397.","journal-title":"Methods Mol Biol"},{"key":"928_CR130","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid Med Cell Longev. 2013;2013: 316523.","DOI":"10.1155\/2013\/316523"},{"issue":"18","key":"928_CR131","doi-asserted-by":"crossref","first-page":"e202500316","DOI":"10.1002\/cbic.202500316","volume":"26","author":"DM Kang","year":"2025","unstructured":"Kang DM, et al. Pathological disulfide bond crosslinking: molecular insights into amyloidogenesis and diseases progression. ChemBioChem. 2025;26(18):e202500316.","journal-title":"ChemBioChem"},{"key":"928_CR132","doi-asserted-by":"crossref","unstructured":"Haque MM, et al. Crosstalk between oxidative stress and tauopathy. Int J Mol Sci. 2019;20(8).","DOI":"10.3390\/ijms20081959"},{"issue":"4","key":"928_CR133","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1523\/JNEUROSCI.1920-20.2020","volume":"41","author":"E Prifti","year":"2021","unstructured":"Prifti E, et al. The two cysteines of tau protein are functionally distinct and contribute differentially to its pathogenicity in vivo. J Neurosci. 2021;41(4):797\u2013810.","journal-title":"J Neurosci"},{"issue":"21","key":"928_CR134","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/hmg\/ddab162","volume":"30","author":"T Saito","year":"2021","unstructured":"Saito T, et al. Disulfide bond formation in microtubule-associated tau protein promotes tau accumulation and toxicity in vivo. Hum Mol Genet. 2021;30(21):1955\u201367.","journal-title":"Hum Mol Genet"},{"key":"928_CR135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nlm.2016.10.013","volume":"138","author":"MA Henson","year":"2017","unstructured":"Henson MA, et al. Long-term depression-associated signaling is required for an in vitro model of NMDA receptor-dependent synapse pruning. Neurobiol Learn Mem. 2017;138:39\u201353.","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"928_CR136","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuron.2008.09.018","volume":"60","author":"N Becker","year":"2008","unstructured":"Becker N, et al. LTD induction causes morphological changes of presynaptic boutons and reduces their contacts with spines. Neuron. 2008;60(4):590\u20137.","journal-title":"Neuron"},{"issue":"3","key":"928_CR137","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/alz.13682","volume":"20","author":"A Gomez-Arboledas","year":"2024","unstructured":"Gomez-Arboledas A, et al. C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(3):2173\u201390.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"928_CR138","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, et al. Changes in the synaptic proteome in tauopathy and rescue of Tau-Induced synapse loss by C1q antibodies. Neuron. 2018;100(6):1322\u2013e13367.","journal-title":"Neuron"},{"issue":"9","key":"928_CR139","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic B, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nat Aging. 2022;2(9):837\u201350.","journal-title":"Nat Aging"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00928-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:59:12Z","timestamp":1781629152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00928-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00928-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.09.19.677215","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human iPSCs used in this study were de-identified. The Buck institutional review board (IRB) of record determined that the project did not meet criteria for human subjects research and waived the requirement for approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}